• Profile
Close

Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: Results from FORTUNE-1, a prospective, multicentre randomised study

Annals of Rheumatic Diseases Feb 12, 2018

Yamanaka H, et al. - Authors, herein, assessed if the use of febuxostat with stepwise dose increase was as useful as colchicine prophylaxis in the reduction of gout flares during the initial introduction of urate-lowering therapy in patients suffering from gout as compared to febuxostat without any dose titration. Gout flares were effectively reduced by the stepwise dose increase of febuxostat and low-dose colchicine prophylaxis as compared to fixed-dose febuxostat alone. During the introduction of urate-lowering therapy, a stepwise dose increase of febuxostat could be an effective alternative to low-dose colchicine prophylaxis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay